These mutants or small molecule inhibitors of TIMP-3 endocytosis may be of use in osteoarthritis as well as in other pathological conditions characterized by excess, dysregulated metalloproteinase activity, such as cancer and chronic diabetic wounds. This evidence concerns the gene TIMP3 and cancer.